Search for: "Pfizer, Inc." Results 801 - 820 of 1,369
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2012, 2:00 am by Steve Lombardi
“Kempema acknowledged selling more than 3,700 pills to 95 customers and agreed to forfeit $23,000, which is expected to go to drugmakers Pfizer Inc. and Eli Lilly and Co. and three customers. [read post]
7 Nov 2015, 2:36 pm by Michael Rosenblat
The Department of Justice is conducting an investigation into the pricing of the Protonix, a heartburn medication sold by Pfizer, the pricing of Humalog, a type of insulin, and Cialis, sold by Lilly. [read post]
20 Oct 2023, 6:37 am by Shane McCall
Pfizer Inc Agrees to Pay $2M to Resolve Alleged Compensation Discrimination at New York City Location SBA Administrator Guzman and Business Leaders Reaffirm Support for 8(a) Program If it does get passed, the Defense authorization bill has quite a few surprises Florida International University Agress to Pay $575K in Back Wages, Interest to Resolve Alleged Gender Pay Discrimination Former Navy IT Manager Sentenced to over 5 Years in Prison for Hacking a Computer… [read post]
6 Oct 2022, 5:23 pm by Sabrina I. Pacifici
The study, led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aimed to define the clinical course and the immunologic and virologic characteristics of COVID-19 rebound in patients who have taken nirmatrelvir/ritonavir (Paxlovid), an antiviral therapeutic developed by Pfizer, Inc. [read post]
13 Sep 2019, 2:58 am by Walter Olson
Shaw’s Supermarkets, Inc. [read post]
11 Jun 2007, 8:03 am
The Court refused to expedite consideration of a new patent appeal by Pfizer Inc., a case in which Justice John Paul Stevens refused last week to provide temporary relief. [read post]
5 Oct 2016, 11:44 am by John Suthers
  In another similar case involving a drug manufacturer, a former sales representative of Pfizer, Inc., brought a qui tam lawsuit, alleging the manufacturer engaged in off-label marketing of its painkiller, Bextra. [read post]
11 Sep 2015, 4:00 am by Alan Macek
Apotex, Inc., [1990] 1 F.C. 221 (F.C.A.), the Court held that evidence on irreparable harm must be “clear and not speculative”. [read post]
5 Oct 2016, 11:44 am by John Suthers
  In another similar case involving a drug manufacturer, a former sales representative of Pfizer, Inc., brought a qui tam lawsuit, alleging the manufacturer engaged in off-label marketing of its painkiller, Bextra. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
24 May 2021, 7:34 am by Deb Givens
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
30 May 2010, 3:55 pm by Anna Christensen
Kellogg, Brown & Root Service, Inc., and Pfizer, Inc. v. [read post]